Skip to main content

Mona Kaleem, MD

Academic Title:

Assistant Professor

Primary Appointment:

Ophthalmology and Visual Sciences

Location:

419 W Redwood Street, Suite 470, Baltimore, MD 21201

Phone (Primary):

667-214-1111 (appointments)

Phone (Secondary):

667-214-1232 (academic office)

Fax:

410-328-1178

Education and Training

  • Smith College, BA, Economics
  • National Institutes of Health, Pre-IRTA Fellowship Program
  • Howard University College of Medicine, MD
  • Internship, Mercy Medical Center
  • Residency, Howard University Hospital, Ophthalmology
  • Fellowship, Cole Eye Institute, Cleveland Clinic Foundation, Glaucoma

Biosketch

Dr. Kaleem is a fellowship trained glaucoma and cataract specialist at the University of Maryland. She is broadly trained in the clinical and surgical care of adult and juvenile glaucoma. Her sub-specialty training was completed at the Cleveland Clinic which is consistently ranked among the top 10 eye hospitals in the United States. Due to her excellence in patient care, teaching, and research activities, she was selected to become a member of the American Glaucoma Society, which is an organization composed of the leading glaucoma surgeons in the country. 

Dr. Kaleem is a long time native of Ellicott City, Maryland. She earned a B.A. in Economics with double minors in Biology and Chemistry at Smith College prior to matriculating at the Howard University College of Medicine where she was a Trustee Scholar and awardee of the Malcolm X Scholarship due to her leadership in community service. She completed her medical training at Mercy Medical Center, Howard University Hospital, and the Cleveland Clinic. 

She has a strong interest in volunteerism and has participated in medical missions in Haiti, India, Honduras and in underserved areas within the United States.

Dr. Kaleem sees patients at the Redwood Building on main campus, Midtown Hospital, Waterloo Crossing in Columbia, Owings Mills, and the Batimore VA Hospital. 

 

Research/Clinical Keywords

Improving quality of life for glaucoma patients, increasing eye care to underserved populations, and integrative medicine.

Highlighted Publications

Kaleem MA, West SK, Im L, Swenor BK. Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers. J Glaucoma. 2018 July;27(7):653-655.

Qin VL, Kaleem M, Rockwood EJ, Singh A, Sood-Mendiratta S, Sears JE, Silva FQ, Conti FF, Eisengart J, Singh RP. Long-term clinical outcomes of pars plana versus anterior chamber placement of glaucoma drainage devices. J Glaucoma. 2018 May;27(5):440-4.

Fontenot JL, Bona MD, Kaleem MA, McLaughlin WM Jr, Morse AR, Schwartz TL, Shepherd JD, Jackson ML; American Academy of Ophthalmology Preferred Practice Pattern Vision Rehabilitation Committee. Ophthalmology. 2018 Jan;125(1):P228-P278. Rehabilitation Preferred Practice Pattern.

Kaleem M, Ridha F, Shwani Z, Swenor B, Goshe J, Singh A. Rates of Intraocular Pressure Elevation and Use of Topical Anti-Hypertensive Medication After Descemet’s Stripping Automated Endothelial Keratoplasty. Cornea. 2017 Jun;36(6):669-67

Pabon S, Sunness JS, Kaleem MA. Low Vision Therapy for Glaucoma Patients.Curr Ophthalmol Rep. 2017. DOI:10.1007/s40135-017-0124-5.

Kaleem MA, West SK, Im L, Swenor BK. Referral to Low Vision Services for Glaucoma Patients: Referral patterns and characteristics of those who refer. J Glaucoma, 2017 Feb;26(2):e115-e120.

 

 

Additional Publication Citations

Miller DW, Wilson CR, Kaleem MA, Blackinton J, Cookson MR. Identification of the epitope of a monoclonal antibody to DJ-1.Neurosci Lett. 2005 Feb 21;374(3):203-6.

Blackinton J, Ahmad R, Miller DW, van der Brug MP, Canet-Aviles RM, Hague SM, Kaleem M, Cookson MR. Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. Brain Res Mol Brain Res. 2005 Mar 24;134(1):76-83.

Bandopadhyay R, Miller DW, Kingsbury AE, Jowett TP, Kaleem M,Pittman AM, de Silva R, Cookson MR, Lees AJ. Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein.Neurosci Lett. 2005 Aug 5;383(3):225-30.

Myers AJ,Kaleem M, Marlowe L, Pittman AM, Lees A, Fung HC, Duckworth J, Leung D, Gibson A, Morris CM, de Silva R and Hardy J. The H1c Haplotype at the MAPT locus is associated with Alzheimer’s Disease.Hum Mol Genet. 2005 Aug 15;14(16):2399-404.

Smemo S, Nowotny P, Hinrichs AL, Kauwe JS, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM, Hollingworth P, O'donovan MC, Morris CM, Holmans P, Lovestone S, Morris JC, Thal L, Li Y, Grupe A, Hardy J, Owen MJ, Williams J, Goate A. Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann Neurol. 2006 Jan;59(1):21-6.

Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L, Tacey K, van Luchene R, Myers A, Wavrant-De Vrieze F, Kaleem M, Hollingworth P, Jehu L, Foy C, Archer N, Hamilton G, Holmans P, Morris CM, Catanese J, Sninsky J, White TJ, Powell J, Hardy J, O'Donovan M, Lovestone S, Jones L, Morris JC, Thal L, Owen M, Williams J, Goate A. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet. 2006 Jan;78(1):78-88.

Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis. 2007 Mar;25(3):561-70.

Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007 Apr;68(4):613-8.

Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007 Jun 7;54(5):713-20.

Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV, Holmans P, Heward CB, Reiman EM, Stephan D, Hardy J. A survey of genetic human cortical gene expression. Nat Genet. 2007 Dec;39(12):1494-9.

Kaleem M, Zhao A, Hamshere M, Myers AJ. Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease.Neurodegener Dis. 2007;4(5):376-81.

Webster JA, Myers AJ, Pearson JV, Craig DW, Hu-Lince D, Coon KD, Zismann VL, Beach T, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Huentelman MJ, Joshipura K, Walker D, Heward CB, Ravid R, Rogers J, Papassotiropoulos A, Hardy J, Reiman EM, Stephan DA. Sorl1 as an Alzheimer's Disease Predisposition Gene?Neurodegener Dis. 2008;5(2):60-4.

Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, Rohrer K, Zhao A, Marlowe L, Kaleem M, McCorquodale DS 3rd, Cuello C, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV; NACC-Neuropathology Group, Heward CB, Reiman EM, Stephan D, Hardy J, Myers AJ. Genetic control of human brain transcript expression in Alzheimer disease.Am J Hum Genet. 2009 Apr;84(4):445-58.

Kaleem MA, Ramsahai S, del Fierro K, Rasul S, Onumah C, Copeland RA, Lerebours, V, Gajjala J, Jones LS. Ocular Findings in Human Immunodeficiency Virus Patients in Washington D.C.International Ophthalmology. 2012 Apr;32(2):145-151.

Kaleem MA, Munoz BE, Munro CA, Gower, EW, West SK. Visual Characteristics of Elderly Night Drivers in the Salisbury Eye Evaluation Driving Study.IOVS. 2012 Aug;53(9):5161-7.

Hwang S, Haidara M, Kaleem MA, Mathews M. Myelomatous Meningitis Presenting as Infiltrative Optic Neuropathy. Advances in Ophthalmology & Visual Systems. 2015 Oct;3(1):72-4.

Kaleem MA, Oberfeld S, Eisengart J. Chronic Pseudophakic Aqueous Misdirection. Asian Journal of Ophthalmology. 2016;15(1):47-52.

Kaleem MA, West SK, Im L, Swenor BK. Referral to Low Vision Services for Glaucoma Patients: Referral patterns and characteristics of those who refer. J Glaucoma, 2017 Feb;26(2):e115-e120.

Schehlein EM, Kaleem MA, Swamy R, Saeedi, OJ. Microinvasive Glaucoma Surgery: An Evidence-Based Assessment. Expert Review of Ophthalmology. Accepted 5/24/17.

Pabon S, Sunness JS, Kaleem MA. Low Vision Therapy for Glaucoma Patients.Curr Ophthalmol Rep. 2017. DOI:10.1007/s40135-017-0124-5.

Kaleem M, Ridha F, Shwani Z, Swenor B, Goshe J, Singh A. Rates of Intraocular Pressure Elevation and Use of Topical Anti-Hypertensive Medication After Descemet’s Stripping Automated Endothelial Keratoplasty. Cornea. 2017 Jun;36(6):669-674.

Schehlein EM, Kaleem MA, Swamy R, Saeedi, OJ. Microinvasive Glaucoma Surgery: An Evidence-Based Assessment. Expert Review of Ophthalmology. Accepted 5/24/17.

Fontenot JL, Bona MD, Kaleem MA, McLaughlin WM, Morse AR, Schwartz TL, Shepherd JD, Jackson ML. Vision Rehabilitation Preferred Practice Pattern. Ophthalmology. 2018 Jan;125(1):228-278.

Qureshi A, Chen H, Saeedi OS, Kaleem M, Margo J, Kalarn S, Alexander J. Anterior Segment Ultrasound Biomicroscopy Image Analysis Using ImageJ Software: Intra-observer Repeatability and Inter-observer Agreement. International Ophthalmology. 2018 March; doi: 10.1007/s10792-018-0882-6

Qin VL, Kaleem M, Rockwood EJ, Singh A, Sood-Mendiratta S, Sears JE, Silva FQ, Conti FF, Eisengart J, Singh RP. Long-term clinical outcomes of pars plana versus anterior chamber placement of glaucoma drainage devices. J Glaucoma. 2018 May;27(5):440-4.

Kaleem MA, West SK, Im L, Swenor BK. Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers. J Glaucoma. 2018 July;27(7):653-655.

 

Clinical Specialty Details

Glaucoma, cataract, comprehensive ophthalmology, advanced laser and surgical procedures.

Awards and Affiliations

Top Doctor, Baltimore Magazine, 2018

 

 

Grants and Contracts

MAPS Award, American Glaucoma Society
Examining the Burden of Ophthalmic Disease in the Underserved in Baltimore, Abell Foundation

Professional Activity

  • American Academy of Ophthalmology 
  • American Glaucoma Society
  • American Society of Cataract and Refractive Surgeons
  • Association of Research in Vision and Ophthalmology
  • Women in Ophthalmology
  • American Association of Physicians of Indian Origin
  • Islamic Medical Association of North America
  • American Medical Association
  • National Medical Assocation 

Links of Interest

Videos

Video Biography

Treatment for Glaucoma

Advances in Glaucoma Treatment